Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul B Yu

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Molecular and Cellular Biology|September 14, 2017
Correction for Bagarova et al., "Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation"Jana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Molecular and Cellular Biology|April 11, 2013
Constitutively active ALK2 receptor mutants require type II receptor cooperationJana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Pulmonary Circulation|September 10, 2013
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertensionRajeev Malhotra, Samuel Paskin-Flerlage, Roham T Zamanian, et al.
Angiogenesis|August 20, 2020
Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cellsRobert Szulcek, Gonzalo Sanchez-Duffhues, Nina Rol, et al.
Blood|February 7, 2014
The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6Claire Mayeur, Lisa K Lohmeyer, Patricio Leyton, et al.
Science Translational Medicine|June 24, 2021
A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossificationQian Cong, Yuchen Liu, Taifeng Zhou, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2014
Specific activin receptor-like kinase 3 inhibitors enhance liver regenerationDaisuke Tsugawa, Yuki Oya, Ryota Masuzaki, et al.
Pulmonary Circulation|January 17, 2017
Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertensionHilary M DuBrock, Josanna M Rodriguez-Lopez, Barbara L LeVarge, et al.
Nature Medicine|January 9, 2026
The NOTCH3 extracellular domain is a serum biomarker for pulmonary arterial hypertensionMoises Hernandez, Nolan M Winicki, Cristian D Puerta, et al.
Nature Medicine|November 26, 2008
BMP type I receptor inhibition reduces heterotopic [corrected] ossificationPaul B Yu, Donna Y Deng, Carol S Lai, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Molecular and Cellular Biology|September 14, 2017
Correction for Bagarova et al., "Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation"Jana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Molecular and Cellular Biology|April 11, 2013
Constitutively active ALK2 receptor mutants require type II receptor cooperationJana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Pulmonary Circulation|September 10, 2013
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertensionRajeev Malhotra, Samuel Paskin-Flerlage, Roham T Zamanian, et al.
Angiogenesis|August 20, 2020
Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cellsRobert Szulcek, Gonzalo Sanchez-Duffhues, Nina Rol, et al.
Blood|February 7, 2014
The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6Claire Mayeur, Lisa K Lohmeyer, Patricio Leyton, et al.
Science Translational Medicine|June 24, 2021
A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossificationQian Cong, Yuchen Liu, Taifeng Zhou, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2014
Specific activin receptor-like kinase 3 inhibitors enhance liver regenerationDaisuke Tsugawa, Yuki Oya, Ryota Masuzaki, et al.
Pulmonary Circulation|January 17, 2017
Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertensionHilary M DuBrock, Josanna M Rodriguez-Lopez, Barbara L LeVarge, et al.
Nature Medicine|January 9, 2026
The NOTCH3 extracellular domain is a serum biomarker for pulmonary arterial hypertensionMoises Hernandez, Nolan M Winicki, Cristian D Puerta, et al.
Nature Medicine|November 26, 2008
BMP type I receptor inhibition reduces heterotopic [corrected] ossificationPaul B Yu, Donna Y Deng, Carol S Lai, et al.
Pageof 11